Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-Current Assets (2016 - 2026)

Neuroone Medical Technologies filings provide 10 years of Non-Current Assets readings, the most recent being $461160.0 for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 34.36% to $461160.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 million, a 28.57% decrease, with the full-year FY2025 number at $559363.0, down 24.31% from a year prior.
  • Non-Current Assets hit $461160.0 in Q1 2026 for Neuroone Medical Technologies, down from $510525.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $879353.0 in Q2 2023 to a low of $461160.0 in Q1 2026.
  • Median Non-Current Assets over the past 5 years was $693233.0 (2022), compared with a mean of $693284.4.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 37.04% in 2023 and later plummeted 34.77% in 2025.
  • Neuroone Medical Technologies' Non-Current Assets stood at $693233.0 in 2022, then increased by 5.21% to $729371.0 in 2023, then increased by 7.31% to $782665.0 in 2024, then plummeted by 34.77% to $510525.0 in 2025, then dropped by 9.67% to $461160.0 in 2026.
  • The last three reported values for Non-Current Assets were $461160.0 (Q1 2026), $510525.0 (Q4 2025), and $559363.0 (Q3 2025) per Business Quant data.